209 related articles for article (PubMed ID: 38711495)
1. Association between pre-biologic T2-biomarker combinations and response to biologics in patients with severe asthma.
Porsbjerg CM; Townend J; Bergeron C; Christoff GC; Katsoulotos GP; Larenas-Linnemann D; Tran TN; Al-Lehebi R; Bosnic-Anticevich SZ; Busby J; Hew M; Kostikas K; Papadopoulos NG; Pfeffer PE; Popov TA; Rhee CK; Sadatsafavi M; Tsai MJ; Ulrik CS; Al-Ahmad M; Altraja A; Beastall A; Bulathsinhala L; Carter V; Cosio BG; Fletton K; Hansen S; Heaney LG; Hubbard RB; Kuna P; Murray RB; Nagano T; Pini L; Cano Rosales DJ; Schleich F; Wechsler ME; Amaral R; Bourdin A; Brusselle GG; Chen W; Chung LP; Denton E; Fonseca JA; Hoyte F; Jackson DJ; Katial R; Kirenga BJ; Koh MS; Ławkiedraj A; Lehtimäki L; Liew MF; Mahboub B; Martin N; Menzies-Gow AN; Pang PH; Papaioannou AI; Patel PH; Perez-De-Llano L; Peters MJ; Ricciardi L; Rodríguez-Cáceres B; Solarte I; Tay TR; Torres-Duque CA; Wang E; Zappa M; Abisheganaden J; Assing KD; Costello RW; Gibson PG; Heffler E; Máspero J; Nicola S; Perng Steve DW; Puggioni F; Salvi S; Sheu CC; Sirena C; Taillé C; Tan TL; Bjermer L; Canonica GW; Iwanaga T; Jiménez-Maldonado L; Taube C; Brussino L; Price DB
Front Immunol; 2024; 15():1361891. PubMed ID: 38711495
[TBL] [Abstract][Full Text] [Related]
2. Baseline FeNO as a prognostic biomarker for subsequent severe asthma exacerbations in patients with uncontrolled, moderate-to-severe asthma receiving placebo in the LIBERTY ASTHMA QUEST study: a post-hoc analysis.
Busse WW; Wenzel SE; Casale TB; FitzGerald JM; Rice MS; Daizadeh N; Deniz Y; Patel N; Harel S; Rowe PJ; Graham NMH; O'Riordan T; Pavord ID
Lancet Respir Med; 2021 Oct; 9(10):1165-1173. PubMed ID: 34181876
[TBL] [Abstract][Full Text] [Related]
3. Retrospective Study on the Association of Biomarkers With Real-world Outcomes of Omalizumab-treated Patients With Allergic Asthma.
Kavati A; Zhdanava M; Ortiz B; Lecocq J; Schiffman B; Pilon D; Ho H; Lefebvre P; Stone B
Clin Ther; 2019 Oct; 41(10):1956-1971. PubMed ID: 31563391
[TBL] [Abstract][Full Text] [Related]
4. Type 2 Low Biomarker Stability and Exacerbations in Severe Uncontrolled Asthma.
Viinanen A; Aakko J; Lassenius MI; Telg G; Nieminen K; Kaijala S; Lehtimäki L; Kankaanranta H
Biomolecules; 2023 Jul; 13(7):. PubMed ID: 37509154
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers for predicting type 2-high and uncontrolled asthma in real-world practice.
Woo SD; Park HS; Jang JH; Lee Y; Yang EM; Ban GY; Kim SH; Shin YS; Ye YM; Park HS
Ann Allergy Asthma Immunol; 2023 Aug; 131(2):209-216.e2. PubMed ID: 37209833
[TBL] [Abstract][Full Text] [Related]
6. Relevance of TH2 Markers in the Assessment and Therapeutic Management of Severe Allergic Asthma: A Real-Life Perspective.
Caminati M; Vianello A; Chieco Bianchi F; Festi G; Guarnieri G; Marchi MR; Micheletto C; Olivieri M; Tognella S; Guerriero M; Senna G;
J Investig Allergol Clin Immunol; 2020; 30(1):35-41. PubMed ID: 30676321
[TBL] [Abstract][Full Text] [Related]
7. Association between biomarkers and house dust mite sublingual immunotherapy in allergic asthma.
Hoshino M; Akitsu K; Kubota K; Ohtawa J
Clin Exp Allergy; 2020 Sep; 50(9):1035-1043. PubMed ID: 32557974
[TBL] [Abstract][Full Text] [Related]
8. Biomarker surrogates do not accurately predict sputum eosinophil and neutrophil percentages in asthmatic subjects.
Hastie AT; Moore WC; Li H; Rector BM; Ortega VE; Pascual RM; Peters SP; Meyers DA; Bleecker ER;
J Allergy Clin Immunol; 2013 Jul; 132(1):72-80. PubMed ID: 23706399
[TBL] [Abstract][Full Text] [Related]
9. Application of structured statistical analyses to identify a biomarker predictive of enhanced tralokinumab efficacy in phase III clinical trials for severe, uncontrolled asthma.
Gottlow M; Svensson DJ; Lipkovich I; Huhn M; Bowen K; Wessman P; Colice G
BMC Pulm Med; 2019 Jul; 19(1):129. PubMed ID: 31315668
[TBL] [Abstract][Full Text] [Related]
10. Use of FeNO to predict anti-IL-5 and IL-5R biologics efficacy in a real-world cohort of adults with severe eosinophilic asthma.
Menigoz C; Dirou S; Chambellan A; Hassoun D; Moui A; Magnan A; Blanc FX
J Asthma; 2023 Jun; 60(6):1162-1170. PubMed ID: 36301080
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of Biologics in Severe, Uncontrolled Asthma Stratified by Blood Eosinophil Count: A Systematic Review.
Korn S; Cook B; Simpson LJ; Llanos JP; Ambrose CS
Adv Ther; 2023 Jul; 40(7):2944-2964. PubMed ID: 37233876
[TBL] [Abstract][Full Text] [Related]
12. Comparative effectiveness of anti-IL5 and anti-IgE biologic classes in patients with severe asthma eligible for both.
Pfeffer PE; Ali N; Murray R; Ulrik C; Tran TN; Maspero J; Peters M; Christoff GC; Sadatsafavi M; Torres-Duque CA; Altraja A; Lehtimäki L; Papadopoulos NG; Salvi S; Costello RW; Cushen B; Heffler E; Iwanaga T; Al-Ahmad M; Larenas-Linnemann D; Kuna P; Fonseca JA; Al-Lehebi R; Rhee CK; Perez-de-Llano L; Perng Steve DW; Mahboub B; Wang E; Goh C; Lyu J; Newell A; Alacqua M; Belevskiy AS; Bhutani M; Bjermer L; Bjornsdottir U; Bourdin A; Bulow AV; Busby J; Canonica GW; Cosio BG; Dorscheid DR; Muñoz-Esquerre M; FitzGerald JM; Gil EG; Gibson PG; Heaney LG; Hew M; Hilberg O; Hoyte F; Jackson DJ; Koh MS; Ko HB; Lee JH; Lehmann S; Chaves Loureiro C; Lúðvíksdóttir D; Menzies-Gow AN; Mitchell P; Papaioannou AI; Popov TA; Porsbjerg CM; Salameh L; Sirena C; Taillé C; Taube C; Tohda Y; Wechsler ME; Price DB
Allergy; 2023 Jul; 78(7):1934-1948. PubMed ID: 36929509
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous evaluation of the fractional exhaled nitric oxide and blood eosinophil count of T2-high endotype in patients with non-cystic fibrosis bronchiectasis.
Chen F; Zeng Z; Huang X; Liu Y
Chron Respir Dis; 2023; 20():14799731231210559. PubMed ID: 37889184
[TBL] [Abstract][Full Text] [Related]
14. Elevated fractional exhaled nitric oxide (FeNO) is a clinical indicator of uncontrolled asthma in children receiving inhaled corticosteroids.
Yin SS; Liu H; Gao X
Int J Clin Pharmacol Ther; 2017 Jan; 55(1):66-77. PubMed ID: 27443657
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the Characteristics of Asthma in Severe and Extremely Severe COPD.
Chen FJ; Lin GP; Huang XY; Liu YL; Zeng ZM; Guo YB
Int J Chron Obstruct Pulmon Dis; 2019; 14():2663-2671. PubMed ID: 31819399
[TBL] [Abstract][Full Text] [Related]
16. Eosinophilic and Noneosinophilic Asthma: An Expert Consensus Framework to Characterize Phenotypes in a Global Real-Life Severe Asthma Cohort.
Heaney LG; Perez de Llano L; Al-Ahmad M; Backer V; Busby J; Canonica GW; Christoff GC; Cosio BG; FitzGerald JM; Heffler E; Iwanaga T; Jackson DJ; Menzies-Gow AN; Papadopoulos NG; Papaioannou AI; Pfeffer PE; Popov TA; Porsbjerg CM; Rhee CK; Sadatsafavi M; Tohda Y; Wang E; Wechsler ME; Alacqua M; Altraja A; Bjermer L; Björnsdóttir US; Bourdin A; Brusselle GG; Buhl R; Costello RW; Hew M; Koh MS; Lehmann S; Lehtimäki L; Peters M; Taillé C; Taube C; Tran TN; Zangrilli J; Bulathsinhala L; Carter VA; Chaudhry I; Eleangovan N; Hosseini N; Kerkhof M; Murray RB; Price CA; Price DB
Chest; 2021 Sep; 160(3):814-830. PubMed ID: 33887242
[TBL] [Abstract][Full Text] [Related]
17. Implication of fraction of exhaled nitric oxide and blood eosinophil count in severe asthma.
Soma T; Iemura H; Naito E; Miyauchi S; Uchida Y; Nakagome K; Nagata M
Allergol Int; 2018 Sep; 67S():S3-S11. PubMed ID: 29754974
[TBL] [Abstract][Full Text] [Related]
18. Predicting asthma morbidity in children using proposed markers of Th2-type inflammation.
Konradsen JR; Skantz E; Nordlund B; Lidegran M; James A; Ono J; Ohta S; Izuhara K; Dahlén SE; Alving K; Hedlin G
Pediatr Allergy Immunol; 2015 Dec; 26(8):772-9. PubMed ID: 26266838
[TBL] [Abstract][Full Text] [Related]
19. Association of elevated fractional exhaled nitric oxide concentration and blood eosinophil count with severe asthma exacerbations.
Price DB; Bosnic-Anticevich S; Pavord ID; Roche N; Halpin DMG; Bjermer L; Usmani OS; Brusselle G; Ming SWY; Rastogi S
Clin Transl Allergy; 2019; 9():41. PubMed ID: 31452870
[TBL] [Abstract][Full Text] [Related]
20. A retrospective cohort study in severe asthma describing commonly measured biomarkers: Eosinophil count and IgE levels.
Haughney J; Morice A; Blyth KG; Lee AJ; Coutts A; McKnight E; Pavord I
Respir Med; 2018 Jan; 134():117-123. PubMed ID: 29413497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
